NexturnBioscience Co. Ltd Capital Reinvestment Ratio
NexturnBioscience Co. Ltd capital reinvestment ratio. NexturnBioscience Co. Ltd (089140) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩4.51 Billion) in capital expenditures (₩286.65 Million). Check 089140 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of NexturnBioscience Co. Ltd (2007–2021)
Capital reinvestment ratio of NexturnBioscience Co. Ltd from 2007 to 2021. This chart tracks NexturnBioscience Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore 089140 net asset momentum to track the company's year-over-year net asset growth rate.
NexturnBioscience Co. Ltd Capital Reinvestment Ratio by Year (2007–2021)
NexturnBioscience Co. Ltd capital reinvestment ratio by year from 2007 to 2021. For the full cash flow conversion analysis, see cash efficiency ratio of NexturnBioscience Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.13x | ₩3.66 Billion | ₩467.60 Million | ▼ -97.5% |
| 2020 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▼ -23.4% |
| 2019 | 6.72x | ₩2.74 Billion | ₩18.38 Billion | ▲ +32348.4% |
| 2018 | 0.02x | ₩9.63 Billion | ₩199.42 Million | ▼ -87.9% |
| 2017 | 0.17x | ₩5.08 Billion | ₩870.45 Million | ▲ +242.6% |
| 2016 | 0.05x | ₩17.88 Billion | ₩893.46 Million | ▼ -89.4% |
| 2015 | 0.47x | ₩1.92 Billion | ₩906.54 Million | ▲ +34050.2% |
| 2014 | 0.00x | ₩6.48 Billion | ₩8.97 Million | ▼ -100.0% |
| 2010 | 5.15x | ₩235.94 Million | ₩1.21 Billion | ▲ +7445.3% |
| 2009 | 0.07x | ₩998.03 Million | ₩68.11 Million | ▼ -67.3% |
| 2008 | 0.21x | ₩945.34 Million | ₩197.16 Million | ▼ -88.1% |
| 2007 | 1.75x | ₩2.26 Billion | ₩3.97 Billion | — |